Sánchez LV, Rodríguez MD, Cifuentes SJP, Román SM, Pérez GC, Bello RI

Language: Spanish
References: 0
Page: 136-145
PDF size: 262.19 Kb.

ABSTRACT

Background: Gorlin-Goltz Syndrome (SGG) is a rare autosomal dominant hereditary disorder characterized by three distinctive abnormalities: predisposition to the development of multiple neoplasms such as medulloblastoma or basal cell carcinoma, palmoplantar depressions and odontogenic jaw drops.
Objective: To describe a case with the Gorlin-Goltz syndrome that represents a strange clinical situation for its incidence.
Case report: A 47 year-old female patient with a Gorlin syndrome who has been operated on several occasions and received treatment with HeberFeron, obtaining complete and partial responses by reducing or eliminating the tumor.
Conclusions: Gorlin-Goltz syndrome is an infrequent disease in medical practice and there is not sufficient evidence to determine the choice treatment for the management of basal cell carcinoma in this disease, so that HeberFERON may be a therapeutic option in the management of these cases.